Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Non Operating Income (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Non Operating Income for 12 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income rose 11220.0% year-over-year to $1.7 million, compared with a TTM value of $2.6 million through Sep 2025, up 1362.22%, and an annual FY2024 reading of $31000.0, down 35.42% over the prior year.
  • Non Operating Income was $1.7 million for Q3 2025 at Arcadia Biosciences, up from $1.1 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $7.5 million in Q1 2021 and bottomed at -$137000.0 in Q4 2024.
  • Average Non Operating Income over 5 years is $720666.7, with a median of $14500.0 recorded in 2022.
  • The sharpest move saw Non Operating Income soared 27490.0% in 2021, then tumbled 1241.67% in 2024.
  • Year by year, Non Operating Income stood at -$100000.0 in 2021, then soared by 96.0% to -$4000.0 in 2022, then surged by 400.0% to $12000.0 in 2023, then crashed by 1241.67% to -$137000.0 in 2024, then skyrocketed by 1339.42% to $1.7 million in 2025.
  • Business Quant data shows Non Operating Income for RKDA at $1.7 million in Q3 2025, $1.1 million in Q2 2025, and -$137000.0 in Q4 2024.